Synergistic MDM2-STAT3 Inhibition Demonstrates Strong Anti-Leukemic Efficacy in Acute Lymphoblastic Leukemia.

An increase in cPARP levels and a decrease in cMyc were also evident in the combination treatment group, as shown in the graph ( Figure 3 F,G), although this difference did not reach statistical significance. 2.4.

also in 111,027 other papers